BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38570106)

  • 1. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
    Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
    Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.
    Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D
    Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
    Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
    Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasmall Zwitterionic Polypeptide-Coordinated Nanohybrids for Highly Efficient Cancer Photothermal Ferrotherapy.
    Du C; Zhou L; Qian J; He M; Zhang ZG; Feng C; Zhang Y; Zhang R; Dong CM
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):44002-44012. PubMed ID: 34494817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Au-Fe
    Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
    J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
    Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
    ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
    Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
    Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
    Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
    Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
    Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
    Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic chemo-photothermal and ferroptosis therapy of polydopamine nanoparticles for esophageal cancer.
    Chen Y; Su M; Jia L; Zhang Z
    Nanomedicine (Lond); 2022 Jul; 17(16):1115-1130. PubMed ID: 36094845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy.
    Yu H; Yan J; Li Z; Song T; Ning F; Tan J; Sun Y
    J Mater Chem B; 2023 Jan; 11(2):415-429. PubMed ID: 36512437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.
    Li X; Zou Q; Zhang J; Zhang P; Zhou X; Yalamarty SSK; Liang X; Liu Y; Zheng Q; Gao J
    Int J Nanomedicine; 2020; 15():6791-6811. PubMed ID: 32982234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.
    Liu Z; Kang R; Yang N; Pan X; Yang J; Yu H; Deng W; Jia Z; Zhang J; Shen Q
    J Colloid Interface Sci; 2024 Mar; 658():100-113. PubMed ID: 38100967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
    Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
    Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
    Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
    Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
    Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
    Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells.
    Mansur AAP; Mansur HS; Leonel AG; Carvalho IC; Lage MCG; Carvalho SM; Krambrock K; Lobato ZIP
    J Mater Chem B; 2020 Aug; 8(32):7166-7188. PubMed ID: 32614035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.